Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1294

Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni

Intended Use: Intended for use as a general-purpose sweetener in foods excluding infant formula and products under the U.S. Department of Agriculture's jurisdiction, at levels determined by current good manufacturing practice.
Basis: Scientific procedures
Notifier: Arzeda Corporation
Notifier Address: 3421 Thorndyke Ave W
Seattle, WA 98119
GRAS Notice (releasable information): GRN 1294 (in PDF) (2.5 MB)
FDA's Letter: Pending
-
-